Valued at a market cap of $71.8 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets minimally ...
Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today ...
Zacks Investment Research on MSN
Boston Scientific (BSX) rises higher than market: Key facts
Boston Scientific (BSX) ended the recent trading session at $48.85, demonstrating a +2.43% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily ...
Shares of leading cardiovascular and medsurg (medical-surgical) technologies providerBoston Scientific (NYSE: BSX) are down 16% as of noon ET on Wednesday, following its fourth-quarter earnings report ...
Boston Scientific provided an update on its CHAMPION-AF clinical trial, which tests its Watchman FLX heart implant versus existing oral anticoagulant (NOAC) treatment options. While management ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
In the latest close session, Boston Scientific (BSX) was down 1.02% at $91.75. The stock's change was less than the S&P 500's daily gain of 0.21%. Elsewhere, the Dow saw an upswing of 1.35%, while the ...
Boston Scientific grew sales and adjusted earnings per share by 16% and 14% in the fourth quarter. However, the company's guidance underwhelmed the market. Ultimately, Boston Scientific's earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results